Response to comment on "Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis".
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 24068734.
- Also identified by DOI 10.1126/scitranslmed.3007442.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Our modeling work suggests that isoniazid preventive therapy (IPT) can be effective in reducing drug-sensitive tuberculosis (TB) and that the risk of IPT driving resistance can be reduced by improving the detection and rapid treatment of individuals with drug-resistant disease and by limiting IPT to those in whom the intervention will have the largest benefit.
Medical subject headings
- Antitubercular Agents
- Isoniazid
- Tuberculosis